AMG-151 is a glucokinase agonist that enhances insulin secretion and lowers fasting plasma glucose (FPG) levels. In clinical evaluations, AMG-151 demonstrated a significant dose-response effect compared to placebo, indicating its potential in managing metabolic disorders. However, its use is associated with a higher incidence of hypoglycemia and hypertriglyceridemia. This compound holds promise for further research into the treatment of type 1 diabetes and related metabolic conditions.
AMG-151 is a glucokinase agonist that enhances insulin secretion and lowers fasting plasma glucose (FPG) levels. In clinical evaluations, AMG-151 demonstrated a significant dose-response effect compared to placebo, indicating its potential in managing metabolic disorders. However, its use is associated with a higher incidence of hypoglycemia and hypertriglyceridemia. This compound holds promise for further research into the treatment of type 1 diabetes and related metabolic conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
